Edited by Stefan Baral, Kevin Fenton and Patrick S. Sullivan
Volume 21 Supplement 2
Results from INTEGRATE - the EU Joint Action on integrating prevention, testing and linkage to care strategies across HIV, viral hepatitis, TB and STIs in Europe
Research
This supplement arises from the Joint Action INTEGRATE which has received funding from the European Union, in the framework of the 3rd Health Programme (2014-2020). The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.
-
Citation: BMC Infectious Diseases 2021 21(Suppl 2):690
-
Increasing integrated testing in community settings through interventions for change, including the Spring European Testing Week
Maximising access to testing by targeting more than one infection is effective in identifying new infections in settings or populations. Within the EU funded Joint Action INTEGRATE, this paper examined the fea...
Citation: BMC Infectious Diseases 2021 21(Suppl 2):874 -
Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain
Indicator condition guided HIV testing is a proven effective strategy for increasing HIV diagnosis in health care facilities. As part of the INTEGRATE Joint Action, we conducted four pilot studies, aiming to i...
Citation: BMC Infectious Diseases 2021 21(Suppl 2):845 -
Acceptability and usability of HIV self-tests in two European countries: findings from surveys of clients at non-governmental organisations in Lithuania and Italy
Uptake of HIV self-tests (HIVST) remains low in Europe. We conducted two separate surveys to understand facilitators and barriers to the use of HIVST in two European countries, as part of the EU INTEGRATE Join...
Citation: BMC Infectious Diseases 2021 21(Suppl 2):844 -
RiskRadar: development and pilot results of a technical intervention targeting combination prevention regarding HIV, viral hepatitis, sexually transmitted infections and tuberculosis
The HIV pandemic impacts the lives of millions and despite the global coordinated response, innovative actions are still needed to end it. A major challenge is the added burden of coinfections such as viral he...
Citation: BMC Infectious Diseases 2021 21(Suppl 2):866 -
Integrating partner notification and contact tracing services across Europe: findings from the Integrate project
Partner notification/contact tracing (PN/CT) is a process whereby people diagnosed with an infectious disease notify their sexual and needle-sharing partners/close contacts and invite them for testing and trea...
Citation: BMC Infectious Diseases 2021 21(Suppl 2):796 -
Quality of life in people living with HIV in Romania and Spain
Health-related quality of life (HRQoL) is a crucial component in assessing and addressing the unmet needs of people, especially those with chronic illnesses such as HIV. The aim of the study was to examine and...
Citation: BMC Infectious Diseases 2021 21(Suppl 2):898 -
Recommendations for collection and integration of community-based testing and linkage to care data into national surveillance, monitoring and evaluation systems for HIV, viral hepatitis and sexually transmitted infections: results from the INTEGRATE Joint Action
National testing strategy, including monitoring and evaluation, is critical in responding to HIV, sexually transmitted infections, and viral hepatitis. Community-based voluntary counselling and testing contrib...
Citation: BMC Infectious Diseases 2021 21(Suppl 2):794 -
Integration of community-based testing data into national HIV surveillance in Poland, Serbia and Slovakia within the framework of INTEGRATE project
Community-based voluntary counselling and testing contributes to early HIV diagnoses among key populations. Testing data from such decentralized services is however often not standardized nor linked to nationa...
Citation: BMC Infectious Diseases 2021 21(Suppl 2):800 -
National multi-stakeholder meetings: a tool to support development of integrated policies and practices for testing and prevention of HIV, viral hepatitis, TB and STIs
Country level policies and practices of testing and care for HIV, viral hepatitis and sexually transmitted infections are lagging behind European recommendations on integration across diseases. Building on pre...
Citation: BMC Infectious Diseases 2021 21(Suppl 2):795
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.4
5-year Journal Impact Factor: 3.3
Source Normalized Impact per Paper (SNIP): 1.106
SCImago Journal Rank (SJR): 1.031
Speed 2023
Submission to first editorial decision (median days): 13
Submission to acceptance (median days): 148
Usage 2023
Downloads: 6,949,317
Altmetric mentions: 28,444
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication